The Journal of Pathology · 1992 · 32 citations · 19 references
Veterinary MedicineOncologyPathologyMonoclonal AntibodiesNeoplasiaTumor PathologyMalignant NeoplasmsMalignant TumorsTumor AntigensTumor HistopathologyTumor ImmunopathologyTumor MorphologyImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingNeoplastic DiseasePlatelet-derived Growth Factor Receptor SignalingPlatelet-derived Growth Factor Receptors
The results of an immunohistochemical study of platelet-derived growth factor receptor (PDGF-R) beta chain in human non-neoplastic mesothelium (35 cases) and in malignant mesothelioma (33 cases) using a murine monoclonal antibody are reported. In approximately half of the malignant mesotheliomas, there was immunoreactivity in the cytoplasm of the neoplastic cells for the beta chain of the PDGF-R. In some cases, there was also membrane immunoreactivity. There were no statistically significant differences between the various mesothelioma subtypes. Immunoreactivity for PDGF-R beta chain was absent in non-neoplastic mesothelium.
19
R G Gronwald, Francis James Grant, Betty Haldeman et al. · Proceedings of the National Academy of Sciences · 1988 · 320 citations · Full text